organic sales growth

搜索文档
WESCO Q1 Earnings Miss Estimates, Sales Slip Y/Y, Stock Rises
ZACKS· 2025-05-03 01:50
文章核心观点 - 2025年第一季度WESCO International业绩有降有升,虽盈利下滑且利润率收缩,但有机销售增长强劲,公司维持2025年财务目标 [1][2][10] 财务业绩 盈利情况 - 2025年第一季度调整后每股收益2.21美元,同比下降3.9%,低于Zacks共识预期0.90% [1] - 公司盈利惊喜历史不一,过去四个季度中一次超预期,三次未达预期,平均负惊喜为1.24% [2] 销售情况 - 净销售额53.4亿美元,同比下降0.1%,但超Zacks共识预期2.10%,有机销售额同比增长5.6% [1] 各业务板块销售情况 - EES业务销售额20.7亿美元,占净销售额38.6%,同比持平,有机销售额同比增长3.4% [3] - CSS业务销售额20亿美元,占净销售额37.4%,同比增长17.3%,有机销售额同比增长18.1% [4] - UBS业务销售额12.8亿美元,占净销售额23.9%,同比下降19.2%,有机销售额同比下降4.9% [5] 利润率情况 - 2025年第一季度毛利率21.1%,同比收缩20个基点,调整后EBITDA利润率5.8%,同比下降50个基点 [6] - 销售、一般和行政费用8.29亿美元,同比增长2.3%,占净销售额比例同比增加40个基点至15.5%,调整后营业利润率4.6%,同比收缩60个基点 [7] 资产负债与现金流情况 - 截至2025年3月31日,现金及现金等价物6.816亿美元,低于2024年12月31日的7.026亿美元 [8] - 第一季度末长期债务51.4亿美元,高于上一季度的50.5亿美元 [8] - 本季度经营活动产生现金2800万美元,远低于上一季度的2.766亿美元,自由现金流940万美元,低于上一季度的2.684亿美元 [8] 财务目标 - 公司维持2025年财务目标,预计有机销售增长2.5%-6.5%,报告基础销售额218-227亿美元 [10] - 预计调整后EBITDA利润率6.7%-7.2%,调整后摊薄每股收益12-14.50美元,自由现金流6-8亿美元 [11] 股票评级与相关公司 - WESCO目前Zacks排名为3(持有) [12] - NCR Atleos Corporation、Synchronoss Technologies和Qualys是Zacks计算机和技术板块中排名较好的股票,分别为1(强力买入)和2(买入) [12] - NCR Atleos将于5月7日公布2025年第一季度业绩,Synchronoss Technologies和Qualys将于5月6日公布 [13]
Why Lincoln Electrical Stock Sputtered by 4% Today
The Motley Fool· 2025-05-01 05:08
Lincoln Electric (LECO -4.36%) investors were hoping Wednesday that their company's first quarterly earnings report of 2025 wouldn't be indicative of how the rest of the year would go. The welding-products maker missed on the consensus analyst profitability estimate, and the market punished it by sending its stock to a more than 4% loss in price. The S&P 500 index (^GSPC 0.15%), meanwhile, rose almost 0.2% on the day.A mixed first quarterFor the quarter, Lincoln Electric's net sales were slightly over $1 bi ...
dsm-firmenich Q1 2025 trading update
Globenewswire· 2025-04-30 13:00
Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), April 30, 2025 dsm-firmenich Q1 2025 trading update Management Report Q1 2025 highlights Good start to the year with strong organic sales and earnings growthProgressing well on 2025 strategic planSale of Feed Enzymes business for €1.5 billion announcedAnimal Nutrition & Health exit process advancing as planned€1 billion share buyback program commenced in AprilFY 2025 outlook unchanged: Adjusted EBITDA at least €2.4 billion Key figures in € ...
McCormick(MKC) - 2025 Q1 - Earnings Call Transcript
2025-03-25 20:00
McCormick & Company (MKC) Q1 2025 Earnings Call March 25, 2025 08:00 AM ET Company Participants Faten Freiha - VP - IRBrendan Foley - Chairman, President & CEOMarcos Gabriel - Executive Vice President & CFOAndrew Lazar - Managing DirectorPeter Galbo - Director - Equity ResearchKen Goldman - Managing DirectorRobert Moskow - Managing Director Max Gumport - Director - Equity ResearchMatthew Smith - Director - Food & Tobacco Conference Call Participants Alexia Howard - AnalystSteve Powers - Equity Research Anal ...